Health evaluation of technologies in health services in Brazil: a scoping review
DOI:
https://doi.org/10.33448/rsd-v10i16.23990Keywords:
Health evaluation; Technology; Health services in Brazil; Health organizations.Abstract
Goal: To outline the main health evaluation (HE) technologies used in health services in Brazil. Method: scoping review in databases, with papers published until July 18 2021. Papers with health evaluation and costs, results and economic indexes were included. All the papers with none of the aforementioned components and literature reviews, unavailable texts, legal opinions and decisions from governmental agencies and papers developed outside Brazil were excluded. Results: In the end, 10 papers were considered for this review. Discussion: The papers showed relevant data, although an improvement of the utilization of health economy concepts are needed for a better methodology in health evaluation. Health evaluation provide efficient evidences for decisions, improving resource deployment, offering safer and better health services, also enhancing health services accessibility. Conclusions: It is vital to include values such as HR appraisal, early return to work, cure, length of stay and costs of evaluated devices in the next health evaluations.
References
Arksey H & O’Malley L (2005). Scoping studies: towards a methodological framework. Int J Soc Res Methodol. https://doi.org/10.1080/1364557032000119616
Armstrong R., Hall B.J., Doyle J. & Waters E. (2011) Cochrane Update. 'Scoping the scope' of a cochrane review. Journal of public health. 33(1):147-150. https://doi.org/10.1093/pubmed/fdr015
Brasil. Ministério da Saúde. Resolução RDC nº 36, de 25 de julho de 2013. Institui ações para a segurança do paciente em serviços de saúde e dá outras providências. Diário Oficial da União, Brasília, DF, 2013.
Brasil. Ministério da Saúde. Agência Nacional de Saúde Suplementar. Receitas e despesas. ANS; 2021. http://www.ans.gov.br/acesso-a-informacao/receitas-e-despesas
Brasil. Ministério da Saúde. (2014). Diretrizes metodológicas: Diretriz de Avaliação Econômica. Secretaria de Ciência, Tecnologia e Insumos Estratégicos; https://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_metodologicas_diretriz_avaliacao_economica.pdf
Correia M. I. T. D., Castro M., Toledo D. O., Farah D., Sansone D., Morais T. R. A. & Araújo G. T. B., Fonseca M. (2020). Nutrition Therapy Cost-Effectiveness Model Indicating How Nutrition May Contribute to the Efficiency and Financial Sustainability of the Health Systems. JPEN. Journal of parenteral and enteral nutrition. 1(11):1-9. https://doi.org/10.1002/jpen.2052
Drummond M. F., Sculpher M. J., Claxton K., Stoddart G. L. & Torrance G. W. (2015). Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press.
Drummond M. F., Sculpher M. J., Torrance G., O. ’Brien B. & Stoddart, G. (2002). Methods for The Economic Evaluation of Health Care Programmes. Oxford: Oxford Medical Publications.
Gomes M. & Romcy H. (2005). Avaliação econômica da utilização de seringa pré-enchida versus seringa preenchida manualmente para flushing em pacientes com cateter venoso central na perspectiva de operadoras de saúde. J bras econ saúde. 10(3):239-245. DOI: 10.21115/JBES.v10.n3.p239-45
Iglesias C. P., Drummond M. F., Rovira J. & Nevalat Project Group (2005). Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. International journal of technology assessment in health care. 2005;21(1):1-14. https://doi.org/10.1017/s0266462305050014
Marcolino, M. S., Polanczyk, C. A., Bovendorp, A. C., Marques, N. S., Silva, L. A., Turquia, C. P. & Ribeiro, A. L. (2016). Economic evaluation of the new oral anticoagulants for the prevention of thromboembolic events: a cost-minimization analysis. Sao Paulo medical journal = Revista paulista de medicina, 134(4), 322-329. https://doi.org/10.1590/1516-3180.2016.0019260216
Mattos Â. Z., Mattos A. A. & Ribeiro R. A. (2016). Rerlipressin versus noradrenaline for hepatorenal syndrome: economic evaluation under the perspective of the Brazilian Public Health System. Arquivos de gastroenterologia. 53(2):123-126. https://doi.org/10.1590/S0004-28032016000200014
Meirelles I. O., Couto D. H. N. & Costa R. S. (2019). Custo-efetividade do pazopanibe comparado ao sunitinibe para câncer renal metastático na perspectiva. Cad Saude Publica. 35(8):1-9. https://doi.org/10.1590/0102-311X00108218
Miranda, M. C., Haddad L., Trindade E., Cassenote A., Hayashi G. Y., Damiani D., Costa F. C., Madureira G., Mendonca B. B. & Bachega T. (2021). The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts. Frontiers in pediatrics. 9(1):1-13. https://doi.org/10.3389/fped.2021.659492
Oliveira R., Mourão T. C., Santana T., Favaretto R. L., Zequi S. C. & Guimarães G. C. (2021). Cost-Effectiveness Analysis of Prostate Cancer Screening in Brazil. Value in health regional issues. 26(1):89-97. https://doi.org/10.1016/j.vhri.2021.02.002
Peixoto H. M., Brito M. A. M., Romero G. A. S., Monteiro W. M., Lacerda M. V. G. & Oliveira M. R. F. (2016). Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon. Malar J. 15(2):1-13. https://doi.org/10.1186/s12936-016-1140-x
Peters M. D., Godfrey C. M., Khalil H., McInerney P., Parker D. & Soares C. B. (2015). Guidance for conducting systematic scoping reviews. International journal of evidence-based healthcare. 13(3):141-146. https://doi.org/10.1097/XEB.0000000000000050
Tricco A. C., Lillie E., Zarin W., O. ’Brien K. K., Colquhoun H., Levac D., Moher D., Peters M. D., Horsley T., Weeks L. & Hempel S. (2018) PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 169(7):467-473. doi:10.7326/M18-0850.
Ubels J., Sable C., Beaton A. Z., Nunes M., Oliveira K., Rabelo L. C., Teixeira I. M., Ruiz G., Rabelo L., Tompsett A. R., Ribeiro A., Sahlen K. G. & Nascimento B. R. (2020). PROVAR+ (Programa de RastreamentO da VAlvopatia Reumática e Outras Doenças Cardiovasculares) investigators. Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil. Global heart. 15(1):1-18. https://doi.org/10.5334/gh.529
Veras B. M., Senna K. M., Correia M. G. & Santos M. S. (2013). Cost-effectiveness analysis on the reutilization of coronary artery catheters in a public hospital in Rio de Janeiro, Brazil. Cad Saude Publica. 29(1):110-120. doi: 10.1590/0102-311x00021813
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Francisco Luciano Cavalcanti Filho; Maria Salete Bessa Jorge; Cybelle Façanha Barreto Medeiros Linard
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
